Clinical trial
Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma
NCT03016156 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- March 15, 2018
- Completion date
- September 30, 2025
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cataracts infantile, glaucoma, congenital, leucocoria, retinoblastoma